glp-1 drugs contraindications Benefits and Risks of Receptor Agonists Outlined The GLP-1 Agonists and Obesity:
Description
M., & Emond, S
Browse AZ Knowledge Centres In-depth, structured guides on every condition & treatment
doi: 10.1038/s41392-024-01931-z
The mechanism is straightforward: GLP-1 RAs enhance glucose-dependent insulin secretion, and stacking that on top of glucose-independent insulin release from exogenous insulin or sulfonylureas removes the glucose-dependent safety brake
Access to medications and affordability of GLP-1s are in payers hands Without adequate payer coverage for GLP-1s, individuals who could benefit from these medications will have to pay out of pocket (OOP)
Behind the scenes, however, is health care claims data that troubles us
